Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Michele Dalla Vestra is active.

Publication


Featured researches published by Michele Dalla Vestra.


Journal of The American Society of Nephrology | 2005

Acute-Phase Markers of Inflammation and Glomerular Structure in Patients with Type 2 Diabetes

Michele Dalla Vestra; Michele Mussap; Pietro Gallina; Marino Bruseghin; Anna Maria Cernigoi; Alois Saller; Mario Plebani; Paola Fioretto

Type 2 diabetes is frequently associated with an inflammatory status; the relationships between low-grade inflammation and diabetic nephropathy are still unclear. The aim of this study was to evaluate the relationships between acute-phase markers of inflammation, glomerular structure, and albumin excretion rate (AER) in type 2 diabetes. In 74 patients with type 2 diabetes (23 normoalbuminuric, 30 microalbuminuric, and 21 proteinuric) fibrinogen, serum amyloid A protein (SAA), C-reactive protein (CRP), and IL-6 were determined. AER was measured on three 24-h urine collections; GFR was measured by 51Cr EDTA plasma clearance. A kidney biopsy was performed, and mesangial fractional volume [Vv(mes/glom)] and glomerular basement membrane (GBM) width were estimated by electron microscopic morphometric analysis. CRP, fibrinogen, SAA, and IL-6 differed among groups, with proteinuric patients having the highest levels. SAA and fibrinogen correlated with AER (P < 0.03 and P < 0.001, respectively). GBM width and Vv(mes/glom) increased from normoalbuminuric to proteinuric patients [P < 0.005 normoalbuminuric and microalbuminuric versus proteinuric for GBM, P < 0.01 normoalbuminuric versus proteinuric for Vv(mes/glom)]. In patients with increased GBM width (> 396 nm), CRP, SAA, and IL-6 were higher than in patients with normal GBM width (P < 0.003, P < 0.004, and P < 0.0004, respectively). GBM width was directly correlated with fibrinogen (r = 0.33, P < 0.002) and IL-6 (r = 0.25 P < 0.05). In conclusion, this study demonstrates that acute-phase markers of inflammation are associated with nephropathy status and GBM thickening, suggesting a role for inflammation in the pathogenesis of diabetic glomerulopathy.


Journal of The American Society of Nephrology | 2002

Effects of Cigarette Smoking on Glomerular Structure and Function in Type 2 Diabetic Patients

Bruno Baggio; Alessandro Budakovic; Michele Dalla Vestra; Alois Saller; Marino Bruseghin; Paola Fioretto

Prospective studies have established smoking as an independent risk factor for diabetic nephropathy, suggesting an adverse effect of smoking on glomerular structure and function. To test this hypothesis, this study evaluated GFR, metabolic profile, and smoking habits in 96 patients with type 2 diabetes and abnormal albumin excretion rate (AER). All patients underwent percutaneous kidney biopsy: mesangial fractional volume [Vv (mes/glom)] and glomerular basement membrane (GBM) width were estimated by electron microscopic morphometric analysis; interstitial fibrosis was estimated semiquantitatively by light microscopy. Forty-eight patients were smokers. Compared with nonsmokers, smokers had higher values of HbA(1c) (P = 0.002), AER (P = 0.026), GFR (P = 0.004), and GBM width (P = 0.002); moreover, GFR was higher in current smokers than in former smokers (P = 0.001), and GBM width was related to heavy smoking (F = 5.4; P = 0.006). Multiple linear regression analyses revealed that HbA(1c) was associated with fasting blood glucose (beta coef = 0.52; P < 0.001), smoking habit (beta coef = 0.31; P < 0.001), insulin therapy (beta coef = 0.22; P = 0.012), and male gender (beta coef = -0.20; P = 0.020); AER was related to Vv (mes/glom) (beta coef = 0.32; P = 0.003), GBM width (beta coef = 0.28; P = 0.016), and interaction between smoking habit and HbA(1c) (beta coef = 0.24; P = 0.040). GFR was negatively correlated with Vv (mes/glom) (beta coef = -0.57; P < 0.001) and age (beta coef = -0.29; P = 0.001) and positively correlated with GBM width (beta coef = 0.27; P = 0.012), heavy current smoking (beta coef = 0.24; P = 0.028), and HbA(1c) (beta coef = 0.28; P = 0.040); GBM width was explained by Vv (mes/glom) (beta coef = 0.53; P < 0.001), interaction between heavy smoking and HbA(1c) levels (beta coef = 0.25; P = 0.003), and diabetes duration (beta coef = 0.23; P = 0.010). Smoking habit did not affect the index of interstitial fibrosis. In conclusion, cigarette smoking affects glomerular structure and function in type 2 diabetes and may be an important factor for the onset and progression of diabetic nephropathy.


International Congress Series | 2003

Diabetic nephropathy: renal structural studies in type 1 and type 2 diabetic patients

Michele Dalla Vestra; Paola Fioretto

Abstract The clinical manifestations of diabetic nephropathy, proteinuria, decreasing glomerular filtration rate and increasing blood pressure are similar in type 1 and type 2 diabetes, while the renal lesions differ. Indeed, in type 1 diabetes, although also tubular, interstitial and arteriolar lesions are present, the most important structural changes involve the glomerulus, in contrast several type 2 diabetic patients, despite the presence of microalbuminuria or proteinuria, have normal glomerular structure with or without tubulo-interstitial and arteriolar abnormalities. The renal functional parameters are strongly related with the structural changes, especially with the degree of mesangial expansion in both type 1 and type 2 diabetes. Previous studies using light and electron microscopic morphometric analyses described the renal structural changes and the structural–functional relationships of diabetic nephropathy. This review focuses on these topics, documenting the contribution of renal biopsy studies in understanding the pathogenesis of diabetic nephropathy and in identifying the patients with higher risk to progress to end-stage renal disease.


Italian Journal of Medicine | 2013

Hypertension and diabetic retinopathy: a simple association?

Michele Dalla Vestra; Natalino Simioni; Giovanni Maurizio Patrassi; Paola Fioretto

BACKGROUND Diabetes is known to be a major contributor to blindness in industrialized countries in adults. In addition to glycemic control, arterial hypertension is emerging as important factor in the development and progression of diabetic retinopathy. AIM OF THE STUDY This review describes the epidemiologic studies that explored the relationships between hypertension and diabetic retinopathy and the potential pathogenetic mechanisms underlying this association. Finally the effects of antihypertensive treatment in primary and secondary prevention of diabetic retinopathy are discussed. CONCLUSIONS The understanding of the pathogenetic mechanisms and risk factors is crucial to establish effective preventive and treatment strategies.


Diabetes | 2003

Is podocyte injury relevant in diabetic nephropathy? Studies in patients with type 2 diabetes.

Michele Dalla Vestra; Alessandra Masiero; Anna Maria Roiter; Alois Saller; Gaetano Crepaldi; Paola Fioretto


Kidney International | 2002

Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients.

Michele Mussap; Michele Dalla Vestra; Paola Fioretto; Alois Saller; Mariacristina Varagnolo; Mario Plebani


Diabetes | 2002

The Angiotensin-Converting Enzyme DD Genotype Is Associated With Glomerulopathy Lesions in Type 2 Diabetes

Anna Solini; Michele Dalla Vestra; Alois Saller; Gaetano Crepaldi; Paola Fioretto


Diabetes Care | 2003

PC-1 amino acid variant Q121 is associated with a lower glomerular filtration rate in type 2 diabetic patients with abnormal albumin excretion rates.

Salvatore De Cosmo; Roberto Trevisan; Michele Dalla Vestra; Monica Vedovato; Alessandra Argiolas; Anna Solini; Alois Saller; Francesco Damone; Antonio Tiengo; Vincenzo Trischitta; Paola Fioretto


International Congress Series | 2007

Diabetic nephropathy: An update on renal structure

Paola Fioretto; Marino Bruseghin; Isabella Barzon; Marco Arboit; Michele Dalla Vestra


Current Diabetes Reports | 2001

Risk predictors in patients with diabetic nephropathy.

Paola Fioretto; Maria Luiza Caramori; Michele Dalla Vestra; Michael Mauer

Collaboration


Dive into the Michele Dalla Vestra's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Alessandra Argiolas

Casa Sollievo della Sofferenza

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge